NERM
PCYC

New England Research & Management’s PHARMACYCLICS INC PCYC Stock Holding History

New England Research & Management’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,325
Closed -$407K – 195
2014
Q4 		$407K Buy
3,325
+50
+2% +$6.39K 0.35% 119
2014
Q3 		$385K Sell
3,275
-125
-4% -$14.2K 0.34% 118
2014
Q2 		$305K Buy
+3,400
New +$319K 0.27% 126

Other funds holding PCYC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

New England Research & Management's PCYC Position: Q1 2015 in Review

New England Research & Management sold out of PHARMACYCLICS INC (PCYC) in Q1 2015, closing a stake of 3,325 shares — an estimated $407K sold.

New England Research & Management first reported a position in PCYC in Q2 2014 and held it in 3 quarters. The position peaked at $407K in Q4 2014. 336 funds tracked by Wall St. Rank hold PCYC as of Q1 2015.

  • New England Research & Management reported no remaining PHARMACYCLICS INC position as of Q1 2015 after selling out during the quarter.
  • New England Research & Management sold 3,325 PHARMACYCLICS INC shares in Q1 2015, an estimated $407K.
  • New England Research & Management first reported a position in PHARMACYCLICS INC in Q2 2014 and held it in 3 quarters.
  • New England Research & Management's PHARMACYCLICS INC position peaked at $407K in Q4 2014.
  • 336 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q1 2015.

Based on New England Research & Management's 13F filing for Q1 2015, filed 6 Apr 2015.